z-logo
open-access-imgOpen Access
Vaccine-Induced Immunogenicity and Protection AgainstPneumocystisPneumonia in a Nonhuman Primate Model of HIV andPneumocystisCoinfection
Author(s) -
Heather M. Kling,
Karen A. Norris
Publication year - 2016
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jiw032
Subject(s) - pneumocystis jirovecii , immunogenicity , virology , pneumocystis carinii , pneumonia , immunology , coinfection , pneumocystis pneumonia , biology , medical microbiology , immune system , virus , medicine , human immunodeficiency virus (hiv)
The ubiquitous opportunistic pathogen Pneumocystis jirovecii causes pneumonia in immunocompromised individuals, including human immunodeficiency virus (HIV)-infected individuals, and pulmonary colonization with P. jirovecii is believed to be a cofactor in the development of chronic obstructive pulmonary disease. There is no vaccine for P. jirovecii; however, most adults are seropositive, indicating natural immune priming to this pathogen. We have shown that humoral response to a recombinant subunit of the P. jirovecii protease kexin (KEX1) correlates with protection from P. jirovecii colonization and pneumonia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom